17(R)‐resolvin D1 specifically inhibits transient receptor potential ion channel vanilloid 3 leading to peripheral antinociception
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
BACKGROUND AND PURPOSE Transient receptor potential ion channel vanilloid 3 (TRPV3) is expressed in skin keratinocytes and plays an important role in thermal and chemical nociceptions in the periphery. The presence of TRPV3 inhibitors would improve our understanding of TRPV3 function and help to develop receptor‐specific analgesics. However, little is known about physiological substances that specifically inhibit TRPV3 activity. Here, we investigated whether 17(R)‐resolvin D1 (17R‐RvD1), a naturally occurring pro‐resolving lipid specifically affects TRPV3 activity. EXPERIMENTAL APPROACH We examined the effect of 17R‐RvD1 on sensory TRP channels using Ca 2+ imaging and whole cell electrophysiology experiments in a HEK cell heterologous expression system, cultured sensory neurons and keratinocytes. We also examined changes in sensory TRP agonist‐specific acute licking/flicking or flinching behaviours and mechanical and thermal pain behaviours using Hargreaves, Randall‐Selitto and von Frey assay systems in the absence and presence of inflammation. KEY RESULTS We showed that 17R‐RvD1 specifically suppresses TRPV3‐mediated activity at nanomolar and micromolar concentrations. The voltage‐dependence of TRPV3 activation by camphor was shifted rightwards by 17R‐RvD1, which indicates its inhibitory mechanism is as a result of a shift in voltage‐dependence. Consistently, TRPV3‐specific acute pain behaviours were attenuated by locally injected 17R‐RvD1. Moreover, the administration of 17R‐RvD1 significantly reversed the thermal hypersensitivity that occurs during an inflammatory response. Knockdown of epidermal TRPV3 blunted these antinociceptive effects of 17R‐RvD1. CONCLUSIONS AND IMPLICATIONS 17R‐RvD1 is a novel natural inhibitory substance specific for TRPV3. The results of our behavioural studies suggest that 17R‐RvD1 has acute analgesic potential via TRPV3‐specific mechanisms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Guide to receptors and channels (GRAC), 5th edition
Alexander, S., Mathie, A., & Peters, J. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01649_1.x · Cited by 1,947 · cited 1×
“All drug/molecular target nomenclature used here conforms to the British Journal of Pharmacology Guide to Receptors and Channels (Alexander et al., 2011).”
MethodSerhan, C. N., Hong, S., Gronert, K., Colgan, S. P., Devchand, P. R., Mirick, G., & Moussignac, R.-L. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020760 · Cited by 1,650 · cited 1×
“A member of docosahexaenoic acidderived series of resolvins, 17(R)-resolvin D1 (17R-RvD1) was discovered in mammalian tissues (Serhan et al., 2002).”
BackgroundLipid mediator class switching during acute inflammation: signals in resolution
Levy, B. D., Clish, C. B., Schmidt, B., Gronert, K., & Serhan, C. N. (2001) · Nature Immunology · doi:10.1038/89759 · Cited by 1,453 · cited 2×
“mostly composed of w-6-derived mediators, and by contrast, w-3-derived mediators contribute to the resolution of inflammation in the late stage (Levy et al., 2001).”
Background
Cited by
Pro-resolving lipid mediators are leads for resolution physiology
Serhan, C. N. (2014) · Nature · doi:10.1038/nature13479 · Cited by 3,041
The resolution code of acute inflammation: Novel pro-resolving lipid mediators in resolution
Serhan, C. N., Chiang, N., & Dalli, J. (2015) · Seminars in Immunology · doi:10.1016/j.smim.2015.03.004 · Cited by 583
Dalli, J., & Serhan, C. N. (2012) · Blood · doi:10.1182/blood-2012-04-423525 · Cited by 547
Lipid Mediators in the Resolution of Inflammation
Serhan, C. N., Chiang, N., Dalli, J., & Levy, B. D. (2015) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a016311 · Cited by 544
Natural resolution of inflammation
Freire, M. O., & Van Dyke, T. E. (2013) · Periodontology 2000 · doi:10.1111/prd.12034 · Cited by 388
Metadata
- Authors
- Bang, S., Yoo, S., Yang, T., Cho, H., & Hwang, S.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2012-01-10
- Volume
- 165
- Issue
- 3
- Pages
- 683-692
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W1528324433
- Cited by
- 148
- References
- 3
- FWCI
- 6.44
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: 17(R)‐resolvin D1 specifically inhibits transient receptor potential ion channel vanilloid 3 leading to peripheral antinociception. https://app.cochat.ai/papers/10.1111/j.1476-5381.2011.01568.x
- The paper
- Bang, S., Yoo, S., Yang, T., Cho, H., & Hwang, S. (2012). 17(R)‐resolvin D1 specifically inhibits transient receptor potential ion channel vanilloid 3 leading to peripheral antinociception. British Journal of Pharmacology. https://doi.org/10.1111/j.1476-5381.2011.01568.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.